Introduction
Advances in transplantation technologies, better patient and donor selection and improved supportive care over the past two decades have significantly improved outcomes of Blood and Marrow Transplantation (BMT) such that 70-80% of those who are alive at 2 years can expect to live long term 1, 2 . Unfortunately many of these survivors experience significant late morbidity and mortality. A collective effect of underlying disease and co-morbidities, prior treatment, the toxicity of conditioning therapies and immunosuppression, and the effects of Graft Versus Host Disease (GvHD) [3] [4] [5] results in a 59% cumulative incidence of developing a chronic health condition by 10 years post-transplant 6 , a 3.5 fold increased risk of developing a severe or life-threatening condition compared to siblings 7 and a 30% lower life expectancy in adult BMT survivors 8 . Each of these long term and late effects are even more profound in adult survivors of childhood BMT [9] [10] [11] . Life-long follow up is therefore essential to optimise the benefit and minimise the prevalence and impact of the adverse late effects of BMT 12 .
Consensus guidelines for screening and preventative practices for long-term survivors of BMT have been available for almost a decade 13, 14 . These guidelines, agreed by seven international BMT organisations, outline the surveillance tests, clinical assessments and preventative care that BMT survivors require at regular intervals, for life, to monitor for recurrent and secondary malignancies, chronic GvHD, infections, respiratory, cardiovascular, renal, musculoskeletal, ocular, oral, gastrointestinal, dermatological and endocrine dysfunction, and psychosocial issues, among others. Given the range of morbidities experienced by BMT survivors it is unsurprising that a BMT survivor receiving follow up care according to these guidelines would require up to 34 assessments annually including health history, clinical examinations, laboratory analysis, diagnostic imaging, psychosocial assessments, health counselling and education, and involve at least 6 clinical specialties 14 . This demand is likely to increase in coming years as the indications for BMT expand, more recipients of BMT survive 15 , knowledge of late effects increases and the BMT physician workforce plateaus' 16, 17 . While there is broad agreement about the necessity for comprehensive follow up of BMT survivors, the demand for long term follow up (LTFU) is placing overwhelming demand on the capacity of transplantation centres (TC) that have historically been responsible for such care. Given the diverse needs of transplant survivors and the variable capacity of TC to provide LTFU 18 , different models for delivery of long-term health care for BMT survivors have been developed. Drawing on experience in both cancer survivorship and chronic care, these models of care include variations of specialised LTFU clinics at BMT centres, referral back to local haematologists and/or primary care providers, shared care models, telemedicine and videoconferencing 12, [19] [20] [21] [22] [23] [24] [25] .
Patterns of BMT activity, BMT survival and issues with BMT LTFU in Australia mimic international trends 26 . BMTs are only performed in selected major urban tertiary centres who have the necessary expertise, training, resources and accreditation. BMT recipients who live in rural and regional areas must relocate to metropolitan areas for the pre, peri and acute post-transplant period. Returning to their homes, many BMT survivors experience difficulties with access to and cost of specialist services, fragmentation of care and poor communication in a complex health care system, which includes public and private services, and are easily lost to follow up, particularly as time from transplant increases. This has meant large variations in care and long term outcomes particularly for BMT units that perform less than 50 allogeneic transplants per year. Establishing an effective model of long term care is essential in order to reduce late effects and prevent premature mortality 12 . We report the results of a cross-sectional study of long-term survivors of BMT in NSW, Australia to identify their preferences for long-term care; to examine the demographic, socioeconomic and transplant factors and sequelae associated with different preferences for follow up; to identify gaps in service provision provided to this vulnerable and high-risk patient group; and to support clinical and health policy decision-making around long-term care.
METHODS

Background to NSW BMT Service
New South Wales (NSW) is Australia's most populous state with a population of ~ 7.5 million and covers an area of 800,628km 2 . Over a third of residents live outside the greater Sydney area 27 . At the time of study commencement there were four adult allogeneic centres in NSW, all based in Sydney and collectively performing approximately 175 BMTs annually 26 . A survey of BMT survivors was undertaken to explore survivors' health status, demographics, service utilisation and follow-up preferences.
Patients and procedures
Potential participants were identified from allogeneic transplant databases from all adult allogeneic TC in NSW. Participants were eligible if they were >18 years of age (at the time of survey) and had undergone an allogeneic BMT at an adult BMT centre between 1 st January 2000 and 31 st December 2012, were >17 years at the time of transplant, could read and write English and could provide consent. Names and phone numbers were provided to the research team. Consenting participants were given the option to self-complete the questionnaire or complete it via a phone interview with one of the researchers. A second round of telephone calls was made to 178 participants who had not returned the survey within a month. All authors had access to primary clinical trial data. The study protocol was approved by the Northern Sydney Local Health District Human Research Ethics Committee (NSLHD Reference: 1207-217M).
Instruments
The Sydney Post BMT Study Survey (SPBS) was developed by the research team from a review of the literature and discussion with patients attending BMT long-term follow-up (LTFU) clinics. The survey comprised 402 questions grouped into 20 domains and included questions relating to specialist referrals and LTFU preferences with respect to location and provider. Other relevant domains included demographics, medical complications, tests and assessments, medications and therapies, infections, vaccinations, complementary therapy use, cancer screening, relationship status income (Australian Dollars (AUD)) and lifestyle factors, following allogeneic BMT. The questionnaire used tick box responses, short answer questions and 5-step Likert scales measuring attitudes and other factors and took approximately 1 hour to complete. The questionnaire was piloted with six BMT survivors in clinic and phone interviews to assess face and content validity and to check for comprehension. For each consenting participant data was collected on dates of diagnosis and transplant, stage/remission status at transplant, transplant conditioning, GvHD prophylaxis, stem cell source and donor type.
Preference for LTFU for specialist care, and health service utilisation were analysed according to a range of demographic, transplant, psychosocial and lifestyle variables assessed using the Functional Assessment of Cancer Therapy -Bone Marrow Transplant (FACT-BMT Version 4) 28, 29 , anxiety stress and depression (The DASS 21) [30] [31] [32] , chronic GVHD (The Chronic GVHD Activity Assessment -Patient Self Report (Form B) 33 and The Lee Chronic GVHD Symptom Scale) 34 and The Post Traumatic Growth Inventory score 35, 36 . For ease of completion all instruments were combined into one booklet.
Statistical analysis
Categorical responses were summarised using frequencies and percentages. Parametric continuous variables were summarised using means and standard deviations, and non-parametric variables using medians, interquartile ranges (IQR) or ranges. Odds ratios and 95% confidence limits, Pearson chi 2 test or Fishers Exact tests were used for comparative analysis of dichotomous categorical variables. Adjusted odds ratios (AOR) to account for potential confounding effects were determined using multivariable logistic regression analysis.
Two sample comparisons of parametric and nonparametric data were determined using the independent t test, and Wilcoxon Rank Sum tests respectively; greater than two sample comparisons were determined using one way Analysis of Variance (ANOVA) and Kruskal Wallis tests, respectively. A two-tailed p value <0.05 was used as the level of statistical significance.
Statistical analysis was performed using STATA version 12.1 statistical package (StataCorp, College Station, TX, USA).
Results
A total of 1,475 Allogeneic BMT were performed in the study period. Of the 667 recipients known to be alive at study sampling, 581 (87%) were contactable and were sent study packs. Four hundred and forty one (66% of total eligible, 76% of those contacted) returned the completed survey. Three percent declined participation.
Of those completing the survey, 250 (57%) were male and 191 (43%) female. The median age of survey respondents was 54 years (Range: 
LTFU Provider preferences
One or more preferences for medical follow-up were indicated by those surveyed ( Figure 1 ). Overall 275 (62.3%) preferred a single provider for their primary transplant follow-up (ie General Practitioner (GP) alone, Local Haematologist (LH) alone or Transplant Physician (TP) alone. An additional 149 (33.8%) preferred a combination of providers, and 17 (3.8%) indicated no preference.
The majority (44.9%) of those surveyed indicated a preference for their Transplant Physician (TP) (alone) to be primarily responsible for their long-term follow-up care. The second preferred option included a combination of TP and LH (14.2%), followed by LH alone (13.1%), GP+LH+TP (7.7%) GP+TP (7.7%), GP alone (4.3%) or GP and LH (4.1%) ( Figure 1 ).
Of the 441 patients surveyed, 329 (74.6%) indicated a follow-up preference that included a TP, 173 (39.2%) a LH, and 105 (23.8%) a GP. Overall 328 of 441 (74%) BMT survivors reported a preference for follow-up at TC alone or in combination with other provider locations -such as satellite clinics linked with a transplant centre (TC) or telemedicine services administered by the primary TC. Of the entire cohort TC alone were the preferred option in 121(27.4%), local haematology practice (LHP) alone was preferred by 57 (12.9%). Twenty-one (5%) indicated a preference for follow-up with GP practice (GPP) alone, 18(4.1%) for telemedicine (TELE) alone and 17 (3.8%) for satellite clinic alone ( Figure 2) . Four of seven patients with post transplantation haematological malignancies (2 relapse, 5 unspecified), nominated a LTFU preference with local haematologist alone.
On univariate analysis variables associated with an increased preference for TC or TC-linked followup included being in a married/defacto relationship (OR=1.67; p=0.04) and sexual dysfunction (OR 2.15; p=0.006). Those in full-time or part time employment indicated a decreased, though nonsignificant preference for follow-up with TC or TC linked services (OR 0.67; p=0.08). On multivariable analysis, no variables showed a significant association with a preference for TC or TC-linked followup. Those reporting increased severity of GVHD symptoms showed a trend towards increased preference for TC or TC linked follow-up (adjusted OR 
Telemedicine location for LTFU (Appendix 3)
Overall 92 of 441 (20.9%) BMT survivors reported a preference for follow-up that included a telehealth facility. Of these, few (18; 19.6%) indicated a preference for LTFU using telehealth alone, with the majority indicating a preference for telehealth in combination with LHP, TC, satellite clinic or GPP.
Patients preferring the use of telehealth in LTFU compared to those who did not tended to be younger (median 52 compared to 55 years; p=0.07), to have significantly higher educational status (p=0.004) and to have been conditioned using a myeloablative regimen (p=0.06).
Higher psychological morbidity in those preferring telemedicine was reflected in higher median DASS21 scores (22 compared to 18; p=0.03), and a trend towards higher self-reported anxiety and/depression (p=0.06). Sexual dysfunction was more commonly reported in those expressing a preference for telemedicine (OR 3. A reduced odds of regular exercise (OR 0.6; 95% CI 0.4, 1.0; p=0.04) was reported in those patients reporting a preference for telemedicine. After adjusting for age, gender, chronic diseases and GVHD severity, exercise remained an independent and significant association with reduced telemedicine preference (AOR 0.46; 95% CI 0.24, 0.87; p=0.02) No significant differences were reported for cGVHD, self-reported severity of GVHD symptoms and Lee GVHD scores in those preferring telehealth compared to non-telehealth based locations for LTFU.
Specialist and allied health referrals
The median number of specialist medical referrals was 3 (IQR 1, 4; range: 0-11) with the most common referral being to ophthalmologists (60.1%), dermatologists (43.7%), and, in women, gynaecologists (51.6%). Forty-eight percent had been referred to 1 or more allied health professionals (Range 0 -6) including physiotherapists (24.3%), dietitians (23.8%) and psychologists (19.0%) (Figure 3 ).
One third (19/57, 33.3%) of those who were within two years of transplantation were attending a hospital or medical /practice facility at least once per month, and of these, 9/19 (47%) were being seen at least weekly. Of those who were two or more years post-transplant, medical practice or hospital attendances were reported at least monthly in 98/376 (26%), and of these 76/98 (77%) were attending a medical facility at least weekly. A requirement to stay overnight, close to the hospital/medical facility was reported by 52/439 (11.8%) of survey respondents. 
Discussion
There is now broad agreement that LTFU is necessary to reduce the mortality and morbidity associated with BMT12,14 How this care should be delivered, however, remains uncertain and contested 20 21. This study is the first to explore the preference of BMT survivors for long-term post-transplant care.
The results of this study confirm what is known about post-BMT survival that health care utilisation by long term BMT survivors is high 37, that chronic GVHD is a major determinant of quality of life 38 and that medical issues, fatigue, depression and emotional distress are high compared to other cancer survivor populations 3,4,39-41. A model of care for LTFU must therefore address the increased health care needs of this population in ways that are sustainable, cost-effective and consistent with the preferences of BMT survivors.
This study demonstrated that the majority of BMT survivors would prefer LTFU with their transplant physicians and that 74% preferred follow-up at a transplant centre or through a satellite clinic or telemedicine service linked with or administered by that transplant centre. One quarter indicated a preference for receiving comprehensive post-transplant care in a 'satellite' clinic staffed by their BMT team situated closer to their place of residence. A number of social factors, including higher income, educational status and sexual morbidity were significantly associated with a preference for satellite care. Fewer patients expressed interest in telemedicine/web-based care, with those interested in these options having higher educational status and sexual morbidity. The observation that exercise was reported less often in those who preferred telemedicine may reflect reduced mobility. The factor that showed the greatest trend towards preference for transplant centre followup was the severity of cGVHD symptoms. In contrast, those in full time or part-time work showed a trend towards decreased preference for TC or TC-linked follow-up, which may reflect a declining dependency on transplant centre-based care as patients' lives return to normal.
These are important findings, particularly for countries like Australia where transplant centres are concentrated in major urban centres, as they provide support for the development of models of care that are responsive to different medical and socio-demographic needs of BMT survivors. But 'devolved' models of post-transplant care that integrate facilities, specialties and models of care beyond the transplant centre are only likely to work where they are sufficiently organised and resourced 42 . In this regard it is noteworthy that recent studies suggest that the survival of BMT patients from rural/regional areas is not inferior if LTFU is carefully and rigorously structured and if there is good communication between referring specialists and GPs [43] [44] [45] . Likewise, it is reassuring that recent data in a range of patient populations, including solid organ transplant recipients and patients with cancer, suggests that satellite clinics staffed by personnel from tertiary hospitals have shown similar patient outcomes, subjective health status and clinical efficiency when compared to tertiary clinics [46] [47] [48] and that telemedicine can be successfully used to deliver preventive health care, including for sexual and relationship counselling, weight management, advice regarding nutrition and exercise and mental health care [49] [50] [51] [52] [53] .
Although the sample size and high response rate (76%) make it likely that these results represent an accurate account of BMT survivor's preferences for long-term care, there are a number of limitations to our study that may limit the generalizability of these results to BMT survivors in other countries and other settings. These limitations are principally a function of our study population and include Australia's geographical size, predominantly urban population, concentration, climate and health system (which includes both universal publicly funded and private health care). Additionally, we did not specifically ask participants if they had private health insurance or relied upon public health care (in large measure as these are not generally regarded as influencing the standard post-BMT care in Australia) and so are not sure of the impact this has on preferences for follow-up. Also, we did not ask about preferences for nurse-led services, which are commonly used in international BMT centres and cancer care but less a feature of BMT care in Australia 54, 55 . It is also possible that the account of patient preferences for post BMT care is compromised by the use of quantitative instruments incorporate dichotomous variables, however each of the instruments used in the study have been validated in the target population and so provide the basis for further qualitative study.
This study has provided important insights into BMT survivor preferences for long-term care in an Australian cohort. Given the number of survivors who opted to prefer LTFU at and/or coordinated by their transplant centre, it is clear that transplant centres need to standardise their follow-up, clearly define referral pathways for ancillary and specialist medical services, ensure LTFU guidelines are disseminated to all relevant health providers and communicated effectively with the range of primary and tertiary care providers involved in post-BMT care 56 . Should other models of care be integrated into the long-term care of BMT survivors, including satellite clinics and telehealth, attention should be paid to the likely adopters of these services and their needs -particularly if these modes of care are chosen for delivery of psychosexual health care and health education. As the success of any model of care is likely to reflect the specific context of its application, further work will be required to establish if this care does indeed decrease morbidity and mortality of longterm BMT survivors. 
